• Aksamentov, I., Roemer, C., Hodcroft, E.,Neher, R., 2021. Nextclade: clade assignment, mutation calling and quality control for viral genomes. Journal of Open Source Software, 6.

  • Altschul, S.F., Gish, W., Miller, W., Myers, E.W.,Lipman, D.J., 1990. Basic local alignment search tool. J Mol Biol, 215, 403-410.

  • An, S.H., Lee, C.Y., Hong, S.M., Song, C.S., Kim, J.H.,Kwon, H.J., 2019. Novel Mutations Evading Avian Immunity around the Receptor Binding Site of the Clade 2.3.2.1c Hemagglutinin Gene Reduce Viral Thermostability and Mammalian Pathogenicity. Viruses, 11.

  • Andreev, K., Jones, J.C., Seiler, P., Kandeil, A., Webby, R.J.,Govorkova, E.A., 2024. Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors. Antiviral Res, 229, 105959.

  • Bai, L., Zhao, Y., Dong, J., Liang, S., Guo, M., Liu, X., Wang, X., Huang, Z., Sun, X., Zhang, Z., et al., 2021. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res, 31, 395-403.

  • Behera, A.K., Chandra, I.,Cherian, S.S., 2016. Molecular dynamics simulation of the effects of single (S221P) and double (S221P and K216E) mutations in the hemagglutinin protein of influenza A H5N1 virus: a study on host receptor specificity. J Biomol Struct Dyn, 34, 2054-2067.

  • Boivin, G., 2013. Detection and management of antiviral resistance for influenza viruses. Influenza Other Respir Viruses, 7 Suppl 3, 18-23.

  • Boltz, D.A., Douangngeun, B., Phommachanh, P., Sinthasak, S., Mondry, R., Obert, C., Seiler, P., Keating, R., Suzuki, Y., Hiramatsu, H., Govorkova, E.A.,Webster, R.G., 2010. Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. J Gen Virol, 91, 949-959.

  • Butler, J., Hooper, K.A., Petrie, S., Lee, R., Maurer-Stroh, S., Reh, L., Guarnaccia, T., Baas, C., Xue, L., Vitesnik, S., Leang, S.K., Mcvernon, J., Kelso, A., Barr, I.G., Mccaw, J.M., Bloom, J.D.,Hurt, A.C., 2014. Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses. PLoS Pathog, 10, e1004065.

  • Chandrasekaran, A., Srinivasan, A., Raman, R., Viswanathan, K., Raguram, S., Tumpey, T.M., Sasisekharan, V.,Sasisekharan, R., 2008. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol, 26, 107-113.

  • Chen, Z., Tsui, J.L., Gutierrez, B., Busch Moreno, S., Du Plessis, L., Deng, X., Cai, J., Bajaj, S., Suchard, M.A., Pybus, O.G., Lemey, P., Kraemer, M.U.G.,Yu, H., 2024. COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses. Science, 386, eadq3003.

  • Chon, I., Win, S.M.K., Phyu, W.W., Saito, R., Kyaw, Y., Win, N.C., Lasham, D.J., Tin, H.H., Tamura, T., Otoguro, T., Wagatsuma, K., Sun, Y., Li, J.,Watanabe, H., 2024. Whole-Genome Analysis of the Influenza A(H1N1)pdm09 Viruses Isolated from Influenza-like Illness Outpatients in Myanmar and Community-Acquired Oseltamivir-Resistant Strains Present from 2015 to 2019. Viruses, 16.

  • Conroy, G., 2023. What's behind China's mysterious wave of childhood pneumonia? Nature, 10.1038/d41586-023-03732-w.

  • De Vries, R.P., Tzarum, N., Peng, W., Thompson, A.J., Ambepitiya Wickramasinghe, I.N., De La Pena, A.T.T., Van Breemen, M.J., Bouwman, K.M., Zhu, X., Mcbride, R., Yu, W., Sanders, R.W., Verheije, M.H., Wilson, I.A.,Paulson, J.C., 2017. A single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human-type receptors. EMBO Mol Med, 9, 1314-1325.

  • Dhanasekaran, V., Sullivan, S., Edwards, K.M., Xie, R., Khvorov, A., Valkenburg, S.A., Cowling, B.J.,Barr, I.G., 2022. Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination. Nat Commun, 13, 1721.

  • Fahim, M., Roshdy, W.H., Deghedy, O., Kamel, R., Naguib, A., Showky, S., Elguindy, N., Abdel Fattah, M., Afifi, S., Mohsen, A., Kandeel, A.,Abdelghaffar, K., 2022. Epidemiology, Disease Severity and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Viruses Coinfection Seen at Egypt Integrated Acute Respiratory Infections Surveillance, 2020-2022. Can J Infect Dis Med Microbiol, 2022, 7497500.

  • Gamblin, S.J.,Skehel, J.J., 2010. Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem, 285, 28403-28409.

  • Garten, R.J., Davis, C.T., Russell, C.A., Shu, B., Lindstrom, S., Balish, A., Sessions, W.M., Xu, X., Skepner, E., Deyde, V., et al., 2009. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science, 325, 197-201.

  • Huang, Y., Li, S., Ye, W., Wang, H., Su, J., Gao, L., Shi, R., Mou, X., Leng, S.X., Xiao, C.,Chen, G., 2025. Viral Infections in Elderly Individuals: A Comprehensive Overview of SARS-CoV-2 and Influenza Susceptibility, Pathogenesis, and Clinical Treatment Strategies. Vaccines (Basel), 13.

  • Huo, X., Fu, J., Dai, Q.,Zhu, F., 2022. Influenza virus subtype/lineage-specific seasonal patterns and age-related infection risk, in Eastern China. J Infect Dev Ctries, 16, 1928-1932.

  • Hurt, A.C., Hardie, K., Wilson, N.J., Deng, Y.M., Osbourn, M., Gehrig, N.,Kelso, A., 2011. Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med, 365, 2541-2542.

  • Imai, M., Watanabe, T., Hatta, M., Das, S.C., Ozawa, M., Shinya, K., Zhong, G., Hanson, A., Katsura, H., Watanabe, S., Li, C., Kawakami, E., Yamada, S., Kiso, M., Suzuki, Y., Maher, E.A., Neumann, G.,Kawaoka, Y., 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature, 486, 420-428.

  • Jayaraman, A., Pappas, C., Raman, R., Belser, J.A., Viswanathan, K., Shriver, Z., Tumpey, T.M.,Sasisekharan, R., 2011. A single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets. PLoS One, 6, e17616.

  • Kawai, N., Ikematsu, H., Iwaki, N., Kondou, K., Hirotsu, N., Kawashima, T., Maeda, T., Tanaka, O., Doniwa, K.,Kashiwagi, S., 2009. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation. J Infect, 59, 207-212.

  • Khare, S., Gurry, C., Freitas, L., Schultz, M.B., Bach, G., Diallo, A., Akite, N., Ho, J., Lee, R.T., Yeo, W., Curation Team, G.C.,Maurer-Stroh, S., 2021. GISAID's Role in Pandemic Response. China CDC Wkly, 3, 1049-1051.

  • Kim, E.H., Nguyen, T.Q., Casel, M.a.B., Rollon, R., Kim, S.M., Kim, Y.I., Yu, K.M., Jang, S.G., Yang, J., Poo, H., Jung, J.U.,Choi, Y.K., 2022. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4(+) T Cell Responses. J Virol, 96, e0187321.

  • Krammer, F., Smith, G.J.D., Fouchier, R.a.M., Peiris, M., Kedzierska, K., Doherty, P.C., Palese, P., Shaw, M.L., Treanor, J., Webster, R.G.,Garcia-Sastre, A., 2018. Influenza. Nat Rev Dis Primers, 4, 3.

  • Lackenby, A., Moran Gilad, J., Pebody, R., Miah, S., Calatayud, L., Bolotin, S., Vipond, I., Muir, P., Guiver, M., Mcmenamin, J., Reynolds, A., Moore, C., Gunson, R., Thompson, C., Galiano, M., Bermingham, A., Ellis, J.,Zambon, M., 2011. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill, 16.

  • Lee, A.J., Carson, S., Reyne, M.I., Marshall, A., Moody, D., Allen, D.M., Allingham, P., Levickas, A., Fitzgerald, A., Bell, S.H., et al., 2024. Wastewater monitoring of human and avian influenza A viruses in Northern Ireland: a genomic surveillance study. Lancet Microbe, 10.1016/s2666-5247(24)00175-7, 100933.

  • Lee, N., Khalenkov, A.M., Lugovtsev, V.Y., Ireland, D.D., Samsonova, A.P., Bovin, N.V., Donnelly, R.P.,Ilyushina, N.A., 2018. The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity. PLoS One, 13, e0195525.

  • Li, X., Dong, Z., Li, J., Dou, C., Tian, D., Ma, Z., Liu, W., Gao, G. F., Bi, Y., 2024. Genetic characteristics of H1N1 influenza virus outbreak in China in early 2023. Virol Sin. 39, 520–523.

  • Mo, J.S., Abente, E.J., Cardenas Perez, M., Sutton, T.C., Cowan, B., Ferreri, L.M., Geiger, G., Gauger, P.C., Perez, D.R., Vincent Baker, A.L.,Rajao, D.S., 2022. Transmission of Human Influenza A Virus in Pigs Selects for Adaptive Mutations on the HA Gene. J Virol, 96, e0148022.

  • Nair, H., Brooks, W.A., Katz, M., Roca, A., Berkley, J.A., Madhi, S.A., Simmerman, J.M., Gordon, A., Sato, M., Howie, S., et al., 2011. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet, 378, 1917-1930.

  • Nelson, M.I., Viboud, C., Simonsen, L., Bennett, R.T., Griesemer, S.B., St George, K., Taylor, J., Spiro, D.J., Sengamalay, N.A., Ghedin, E., Taubenberger, J.K.,Holmes, E.C., 2008. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog, 4, e1000012.

  • Olsen, S.J., Azziz-Baumgartner, E., Budd, A.P., Brammer, L., Sullivan, S., Pineda, R.F., Cohen, C.,Fry, A.M., 2020. Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep, 69, 1305-1309.

  • Peng, Y., Wang, D., Wang, J., Li, K., Tan, Z., Shu, Y.,Jiang, T., 2017. A universal computational model for predicting antigenic variants of influenza A virus based on conserved antigenic structures. Sci Rep, 7, 42051.

  • Suchard, M.A., Lemey, P., Baele, G., Ayres, D.L., Drummond, A.J.,Rambaut, A., 2018. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol, 4, vey016.

  • Takashita, E., Kiso, M., Fujisaki, S., Yokoyama, M., Nakamura, K., Shirakura, M., Sato, H., Odagiri, T., Kawaoka, Y.,Tashiro, M., 2015. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan. Antimicrob Agents Chemother, 59, 2607-2617.

  • Tang, C.Y., Boftsi, M., Staudt, L., Mcelroy, J.A., Li, T., Duong, S., Ohler, A., Ritter, D., Hammer, R., Hang, J.,Wan, X.F., 2022. SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season. Virology, 576, 105-110.

  • Tsou, T.P., Su, C.P., Huang, W.T., Yang, J.R.,Liu, M.T., 2017. Influenza A(H3N2) virus variants and patient characteristics during a summer influenza epidemic in Taiwan, 2017. Euro Surveill, 22.

  • Wagner, R., Matrosovich, M.,Klenk, H.D., 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol, 12, 159-166.

  • Wang, W., Lu, B., Zhou, H., Suguitan, A.L., Jr., Cheng, X., Subbarao, K., Kemble, G.,Jin, H., 2010. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J Virol, 84, 6570-6577.

  • Wedde, M., Biere, B., Wolff, T.,Schweiger, B., 2015. Evolution of the hemagglutinin expressed by human influenza A(H1N1)pdm09 and A(H3N2) viruses circulating between 2008-2009 and 2013-2014 in Germany. Int J Med Microbiol, 305, 762-775.

  • Xing, L., Chen, Y., Chen, B., Bu, L., Liu, Y., Zeng, Z., Guan, W., Chen, Q., Lin, Y., Qin, K., Chen, H., Deng, X., Wang, X.,Song, W., 2021. Antigenic Drift of the Hemagglutinin from an Influenza A (H1N1) pdm09 Clinical Isolate Increases its Pathogenicity In Vitro. Virol Sin, 36, 1220-1227.

  • Ye, J., Sorrell, E.M., Cai, Y., Shao, H., Xu, K., Pena, L., Hickman, D., Song, H., Angel, M., Medina, R.A., Manicassamy, B., Garcia-Sastre, A.,Perez, D.R., 2010. Variations in the hemagglutinin of the 2009 H1N1 pandemic virus: potential for strains with altered virulence phenotype? PLoS Pathog, 6, e1001145.

  • Zhao, X., Gu, Y., Tang, X., Jiang, C., Fang, F., Chu, W., Tao, L., Zhang, X., Chen, M., Wu, H., Xie, Y., Liu, J.,Teng, Z., 2024. Whole-genome analysis of circulating influenza A virus (H3N2) strains in Shanghai, China from 2005 to 2023. Emerg Microbes Infect, 13, 2396867.